Clinical Trial Update: Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations [NA]

View source ↗

Summary

A terminated clinical trial evaluating recombinant human chorionic gonadotropin for preventing breast cancer in premenopausal women with BRCA1 mutations; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brca1-related Breast Cancer Risk
• Breast Cancer

Drugs mentioned

• Recombinant human chorionic gonadotropin (Choriogonadotropin alfa)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: BRCA1 Mutation, Breast Cancer | NA | Status: TERMINATED | Results posted: 2021-01-25